[Decrease of glucose tolerance and insulin secretion after infusion with ammonium salts in normal humans and patients with fatty liver or liver cirrhosis].
D000328:Adult; D000641:Ammonia / Q000097:blood; D003864:Depression, Chemical; D005234:Fatty Liver / Q000378:metabolism*; D005947:Glucose / Q000378:metabolism*; D005951:Glucose Tolerance Test; D006501:Hepatic Encephalopathy / Q000209:etiology; D006801:Humans; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D008103:Liver Cirrhosis / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D000644:Quaternary Ammonium Compounds / Q000494:pharmacology*; D012636:Secretory Rate / Q000187:drug effects
D007328:Insulin; D000644:Quaternary Ammonium Compounds; D000641:Ammonia; D005947:Glucose
Diminution de la tolérance glucosée et de l'insulino-secrétion après perfusion de sels d'ammonium chez l'homme normal et chez des malades atteints de stéatose hépatique ou de cirrhose